ArticleReproductive sciences (Thousand Oaks, Calif.)2022

Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model.

Natalia Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.